MTEER

COAPT’s Benefit With MTEER Appears Transportable to Contemporary U.S. Practice in Secondary Mitral Regurgitation

A transportability analysis suggests the benefits seen in COAPT would likely persist in real-world U.S. patients with secondary mitral regurgitation if COAPT-style care, including optimized medical therapy, were delivered.